Efficacy and Safety of Sevofran in Patients Scheduled for Elective Surgery Under General Anesthesia

PHASE4CompletedINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

March 31, 2010

Conditions
General AnesthesiaSevofluraneGeneric Drugs
Interventions
DRUG

original sevoflurane

Sevoflurane content: 99.9985%, compound A: 4.6 ppm, water content (sample was opened, sealed and stored for 2 weeks): 0.072% w/v

DRUG

generic sevoflurane

Sevoflurane content: 99.99%, compound A: 3.8 ppm, water content (sample was opened, sealed and stored for 2 weeks) : 0.044% w/v

Trial Locations (2)

138-736

Asan Medical Center, Seoul

139-707

Sanggye-Paik Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

National Clinical Research Coordination Center, Seoul, Korea

OTHER_GOV

lead

Asan Medical Center

OTHER

NCT01096212 - Efficacy and Safety of Sevofran in Patients Scheduled for Elective Surgery Under General Anesthesia | Biotech Hunter | Biotech Hunter